999 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PFE Pfizer, Inc. $43.01 $252.13B N/A
Article Searches
Boost Your Portfolio's Health With These 3 Big Drug Stocks http://www.zacks.com/stock/news/428332/boost-your-portfolios-health-with-these-3-big-drug-stocks?cid=CS-ZC-FT-428332 Jun 12, 2019 - The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.
Lilly's Emgality Gets FDA Approval for Cluster Headache http://www.zacks.com/stock/news/425463/lillys-emgality-gets-fda-approval-for-cluster-headache?cid=CS-ZC-FT-425463 Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft http://www.zacks.com/stock/news/425457/zacks-market-edge-highlights-pfizer-vanguard-sp-500-etf-global-x-social-media-etf-kraneshares-china-internet-etf-and-microsoft?cid=CS-ZC-FT-425457 Jun 06, 2019 - Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft
5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug https://www.fool.com/investing/2019/06/06/5-reasons-pfizer-sat-on-a-potential-new-alzheimers.aspx?source=iedfolrf0000001 Jun 06, 2019 - America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.
Blueprint Medicines to File NDA for Avapritinib With FDA http://www.zacks.com/stock/news/425083/blueprint-medicines-to-file-nda-for-avapritinib-with-fda?cid=CS-ZC-FT-425083 Jun 05, 2019 - Blueprint Medicines' (BPMC) excessive confidence in partners for revenue recognition is still a huge cause for concern.
Top Tips for Long-Term Stock Investors http://www.zacks.com/stock/news/425077/top-tips-for-long-term-stock-investors?cid=CS-ZC-FT-425077 Jun 05, 2019 - The stock market is volatile again. Here's how to make it through the ups and downs.
The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG http://www.zacks.com/stock/news/425031/the-zacks-analyst-blog-highlights-pfizer-coca-cola-vmware-nike-and-aig?cid=CS-ZC-FT-425031 Jun 05, 2019 - The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG
10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors https://www.fool.com/investing/2019/06/05/10-jaw-dropping-numbers-about-cancer-drug-developm.aspx?source=iedfolrf0000001 Jun 05, 2019 - There's more good news with the fight against cancer than you might think.
Top Research Reports for Pfizer, Coca-Cola & VMware http://www.zacks.com/research-daily/424605/top-research-reports-for-pfizer-coca-cola-vmware?cid=CS-ZC-FT-424605 Jun 04, 2019 - Top Research Reports for Pfizer, Coca-Cola & VMware
Blueprint Medicines' NDA for Avapritinib on Track for GIST http://www.zacks.com/stock/news/423983/blueprint-medicines-nda-for-avapritinib-on-track-for-gist?cid=CS-ZC-FT-423983 Jun 03, 2019 - Blueprint Medicines (BPMC) reports data on avapritinib from NAVIGATOR study for treating patients with PDGFRA Exon 18 mutant GIST and the fourth-line GIST.

Pages: 1234567...100

<Page 2>